Streamex Corp. Announces Name Change, Expands Business Model and Growth Strategy
PorAinvest
miércoles, 10 de septiembre de 2025, 11:55 am ET1 min de lectura
BSGM--
The rebranding follows the recent merger with Streamex Exchange Corporation, a real-world asset (RWA) tokenization company. Streamex Exchange Corporation, now a wholly-owned subsidiary of BioSig Technologies, Inc., specializes in bringing the gold and commodities market onto the blockchain. This merger aims to leverage Streamex's advanced tokenization technology to modernize the commodities market .
The rebranding will not require shareholders to take any action, as the CUSIP number remains unchanged. Shareholders will continue to hold their stock under the new name and trading symbol, "STEX," which will commence trading on the Nasdaq Capital Market exchange on September 12, 2025. The corporate structure and operations will remain unchanged [1].
BioSig Technologies, Inc., now known as Streamex Corp., is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform. This platform delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The rebranding reflects the company's expansion into the RWA tokenization sector, marking a significant shift in its business focus .
The company has issued a press release detailing the rebranding and the merger, emphasizing the strategic importance of the move. The forward-looking statements in the press release highlight potential risks and uncertainties associated with the acquisition and compliance with Nasdaq's listing criteria [1].
Investors and financial professionals are encouraged to review the company's filings with the Securities and Exchange Commission for more detailed information, including the section titled "Risk Factors" in the Annual Report on Form 10-K, filed on April 15, 2025 [1].
References:
[1]: BioSig Technologies, Inc. (2025). BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp. Retrieved from [https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html](https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html)
: BioSig and Streamex. (2025). About Streamex Exchange Corporation. Retrieved from [https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html](https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html)
BioSig Technologies is rebranding to Streamex Corp., with a new ticker symbol "STEX", to focus on its expanded business model and growth strategy. The company has merged with Streamex Exchange Corporation, a real-world asset tokenization company, to bring the gold and commodities market on-chain. The rebranding is effective September 12, 2025, and all stock trading, filings, and market-related information will be reported under the new symbol.
BioSig Technologies, Inc. (NASDAQ: BSGM) has announced a significant corporate rebranding to Streamex Corp. The rebranding will take effect on September 12, 2025, and will be accompanied by a change in the company's ticker symbol to "STEX." This strategic move is part of the company's expanded business model and growth strategy [1].The rebranding follows the recent merger with Streamex Exchange Corporation, a real-world asset (RWA) tokenization company. Streamex Exchange Corporation, now a wholly-owned subsidiary of BioSig Technologies, Inc., specializes in bringing the gold and commodities market onto the blockchain. This merger aims to leverage Streamex's advanced tokenization technology to modernize the commodities market .
The rebranding will not require shareholders to take any action, as the CUSIP number remains unchanged. Shareholders will continue to hold their stock under the new name and trading symbol, "STEX," which will commence trading on the Nasdaq Capital Market exchange on September 12, 2025. The corporate structure and operations will remain unchanged [1].
BioSig Technologies, Inc., now known as Streamex Corp., is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform. This platform delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The rebranding reflects the company's expansion into the RWA tokenization sector, marking a significant shift in its business focus .
The company has issued a press release detailing the rebranding and the merger, emphasizing the strategic importance of the move. The forward-looking statements in the press release highlight potential risks and uncertainties associated with the acquisition and compliance with Nasdaq's listing criteria [1].
Investors and financial professionals are encouraged to review the company's filings with the Securities and Exchange Commission for more detailed information, including the section titled "Risk Factors" in the Annual Report on Form 10-K, filed on April 15, 2025 [1].
References:
[1]: BioSig Technologies, Inc. (2025). BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp. Retrieved from [https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html](https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html)
: BioSig and Streamex. (2025). About Streamex Exchange Corporation. Retrieved from [https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html](https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html)

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios